Family Practice Vol. 19, No. 6, 596-604
© Oxford University Press 2002
Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey
a Division of Primary Care, Public and Occupational Health, Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, UK and
b Cardiology Research Unit, University of Lund, Malmö University Hospital, Malmö, Sweden.
Correspondence to FDR Hobbs. E-mail: hobbs{at}bham.ac.uk
Background. Although primary care is the major target of coronary heart disease (CHD) clinical recommendations, little is known of how community physicians view guidelines and their implementation. The REACT survey was designed to assess the views, and perceived implementation, of CHD and lipid treatment guidelines among primary care physicians.
Methods. Semi-structured validated telephone interviews were conducted, in the relevant native tongue, with 754 randomly selected primary care physicians (GPs and family doctors) in five European countries (France, Germany, Italy, Sweden and the UK).
Results. Most physicians (89%) agreed with the content of current guidelines and reported use of them (81%). However, only 18% of physicians believed that guidelines were being implemented to a major extent. Key barriers to greater implementation of guidelines were seen as lack of time (38% of all physicians), prescription costs (30%), and patient compliance (17%). Suggestions for ways to improve implementation centred on more education, both for physicians themselves (29%) and patients (25%); promoting, publicizing or increasing guideline availability (23%); simplifying the guidelines (17%); and making them clearer (12%). Physicians perceived diabetes to be the most important risk factor for CHD, followed by hypertension and raised LDL-C. Most physicians (92%) believe their patients do associate high cholesterol levels with CHD. After establishing that a patient is ‘at risk’ of CHD, physicians reported spending an average of 16.5 minutes discussing risk factors and lifestyle changes or treatment that is required. Factors preventing this included insufficient time (42%), having too many other patients to see (27%) and feeling that patients did not listen or understand anyway (21%).
Conclusions. Primary care physicians need more information and support on the implementation of CHD and cholesterol guideline recommendations. This need is recognized by clinicians.
Keywords. Cholesterol, coronary heart disease, guidelines, risk factors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J Dunkley, M. A Stone, N. Patel, M. J Davies, and K. Khunti Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population Fam. Pract., October 1, 2009; 26(5): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Geller, S. Cassens, M. Brosz, U. Keil, J. Bernarding, S. Kropf, R. A. Bierwirth, B. Lippmann-Grob, H.-P. Schultheiss, K. Schluter, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study Eur. Heart J., December 2, 2007; 28(24): 3051 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Perk High time to join hands between family medicine and cardiology! Eur. Heart J., December 2, 2007; 28(24): 2962 - 2963. [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hobbs Concordance with heart failure medications: what do patients think? Fam. Pract., December 1, 2006; 23(6): 607 - 608. [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Leiter, D J. Betteridge, A. R Chacra, A. Chait, E. Ferrannini, S. M Haffner, T. Kadowaki, J. Tuomilehto, P. Zimmet, C. B Newman, et al. AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 31 - 40. [Abstract] [PDF]
|
|
|
|
|
|
C. Ballantyne, B. Arroll, and J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J., November 1, 2005; 26(21): 2224 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Erhardt Managing cardiovascular risk: reality vs. perception Eur. Heart J. Suppl., November 1, 2005; 7(suppl_L): L11 - L15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Clark, I N Findlay, and for the Have a Heart Paisley IT Group Improving evidence based cardiac care and policy implementation over the patient journey: the potential of coronary heart disease registers Heart, September 1, 2005; 91(9): 1127 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lindberg, M. Lind, S. Petersson, and S. Wilhelmsson The use of clinical guidelines for asthma, diabetes, and hypertension in primary health care Int. J. Qual. Health Care, June 1, 2005; 17(3): 217 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Kasje, P. Denig, P. A. de Graeff, and F. M. Haaijer-Ruskamp Physicians' views on joint treatment guidelines for primary and secondary care Int. J. Qual. Health Care, June 1, 2004; 16(3): 229 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F D R Hobbs Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia Heart, June 1, 2004; 90(suppl_4): iv22 - iv25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Lear, A. Ignaszewski, W. Linden, A. Brozic, M. Kiess, J. J. Spinelli, P. Haydn Pritchard, and J. J. Frohlich The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial Eur. Heart J., November 1, 2003; 24(21): 1920 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. Abholz and C. Oriol Coronary heart disease: acceptance of guideline recommendations irrelevant in Germany? Fam. Pract., June 1, 2003; 20(3): 350 - 350. [Full Text] [PDF]
|
|
|
|
|
|
Y. Samarasinghe, M. Al-Mrayat, M. Vloemans, and N. Munro NICE guidelines for management of lipids in type 2 diabetes mellitus: a practical interpretation The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 222 - 225. [PDF]
|
|
|
|
|
|
M Davis Current targets: where are we going? Heart, May 1, 2003; 89(90002): ii6 - 9. [Abstract] [Full Text] [PDF]
|
|